Ile-Phe
Need Assistance?
  • US & Canada:
    +
  • UK: +

Ile-Phe

* Please kindly note that our products are not to be used for therapeutic purposes and cannot be sold to patients.

Ile-Phe and similar dipeptides may serve as models for studying the first steps of the aggregation/fibrillation of amyloid peptides.

Category
Others
Catalog number
BAT-015486
CAS number
22951-98-0
Molecular Formula
C15H22N2O3
Molecular Weight
278.35
Ile-Phe
IUPAC Name
(2S)-2-[[(2S,3S)-2-amino-3-methylpentanoyl]amino]-3-phenylpropanoic acid
Synonyms
Isoleucyl-Phenylalanine; L-Ile-L-Phe; L-Phenylalanine,L-isoleucyl-
Appearance
White to Off-White Solid
Melting Point
>249°C (dec.)
Sequence
H-Ile-Phe-OH
Storage
Store at -20°C
Solubility
Soluble in Methanol (Slightly, Sonicated)
InChI
InChI=1S/C15H22N2O3/c1-3-10(2)13(16)14(18)17-12(15(19)20)9-11-7-5-4-6-8-11/h4-8,10,12-13H,3,9,16H2,1-2H3,(H,17,18)(H,19,20)/t10-,12-,13-/m0/s1
InChI Key
WMDZARSFSMZOQO-DRZSPHRISA-N
Canonical SMILES
CCC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N
1. Ile-phe dipeptide self-assembly: clues to amyloid formation
Natalia Sánchez de Groot, Teodor Parella, Francesc X Aviles, Josep Vendrell, Salvador Ventura Biophys J. 2007 Mar 1;92(5):1732-41. doi: 10.1529/biophysj.106.096677. Epub 2006 Dec 15.
Peptidic self-assembled nanostructures are said to have a wide range of applications in nanotechnology, yet the mechanistic details of hierarchical self-assembly are still poorly understood. The Phe-Phe recognition motif of the Alzheimer's Abeta peptide is the smallest peptide able to assemble into higher-order structures. Here, we show that the Ile-Phe dipeptide analog is also able to self-associate in aqueous solution as a transparent, thermoreversible gel formed by a network of fibrillar nanostructures that exhibit strong birefringence upon Congo red binding. Besides, a second dipeptide Val-Phe, differing only in a methyl group from the former, is unable to self-assemble. The detailed analysis of the differential polymeric behavior of these closely related molecules provides insight into the forces triggering the first steps in self-assembly processes such as amyloid formation.
2. Dissecting peripheral protein-membrane interfaces
Thibault Tubiana, Ian Sillitoe, Christine Orengo, Nathalie Reuter PLoS Comput Biol. 2022 Dec 14;18(12):e1010346. doi: 10.1371/journal.pcbi.1010346. eCollection 2022 Dec.
Peripheral membrane proteins (PMPs) include a wide variety of proteins that have in common to bind transiently to the chemically complex interfacial region of membranes through their interfacial binding site (IBS). In contrast to protein-protein or protein-DNA/RNA interfaces, peripheral protein-membrane interfaces are poorly characterized. We collected a dataset of PMP domains representative of the variety of PMP functions: membrane-targeting domains (Annexin, C1, C2, discoidin C2, PH, PX), enzymes (PLA, PLC/D) and lipid-transfer proteins (START). The dataset contains 1328 experimental structures and 1194 AphaFold models. We mapped the amino acid composition and structural patterns of the IBS of each protein in this dataset, and evaluated which were more likely to be found at the IBS compared to the rest of the domains' accessible surface. In agreement with earlier work we find that about two thirds of the PMPs in the dataset have protruding hydrophobes (Leu, Ile, Phe, Tyr, Trp and Met) at their IBS. The three aromatic amino acids Trp, Tyr and Phe are a hallmark of PMPs IBS regardless of whether they protrude on loops or not. This is also the case for lysines but not arginines suggesting that, unlike for Arg-rich membrane-active peptides, the less membrane-disruptive lysine is preferred in PMPs. Another striking observation was the over-representation of glycines at the IBS of PMPs compared to the rest of their surface, possibly procuring IBS loops a much-needed flexibility to insert in-between membrane lipids. The analysis of the 9 superfamilies revealed amino acid distribution patterns in agreement with their known functions and membrane-binding mechanisms. Besides revealing novel amino acids patterns at protein-membrane interfaces, our work contributes a new PMP dataset and an analysis pipeline that can be further built upon for future studies of PMPs properties, or for developing PMPs prediction tools using for example, machine learning approaches.
3. Met-Ile-Phe-Leu derivatives: full and partial agonists of human neutrophil formylpeptide receptors
A Dalpiaz, A Scatturin, G Vertuani, R Pecoraro, P A Borea, K Varani, S Traniello, S Spisani Eur J Pharmacol. 2001 Jan 12;411(3):327-33. doi: 10.1016/s0014-2999(00)00908-0.
The biological action of a series of Met-Ile-Phe-Leu analogues was analyzed on human neutrophils, to evaluate their ability to interact with formylpeptide receptors and to induce the related neutrophil responses. Three in vitro assays were carried out: receptor binding, chemotaxis and superoxide anion release. Our results demonstrate that formyl-Met-Ile-Phe-Leu derivatives act as more potent full agonists than formyl-Met-Leu-Phe, the tripeptide normally used as a model chemoattractant for the study of cell functions. On the other hand, the presence of N-ureidoisopropyl substituent in tetrapeptides imparts weak partial agonist properties. It has furthermore been demonstrated that the C-terminal methyl esterification or amination weakly influences the properties of tetrapeptide homologues. Finally, t-Boc-Met-Ile-Phe-Leu derivatives do not appear able to interact with formylpeptide receptors.
Online Inquiry
Verification code
Inquiry Basket